Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NEOS

Neos Therapeutics (NEOS) Stock Price, News & Analysis

Neos Therapeutics logo

About Neos Therapeutics Stock (NASDAQ:NEOS)

Advanced Chart

Key Stats

Today's Range
$1.06
$1.18
50-Day Range
$0.77
$1.18
52-Week Range
$0.45
$1.68
Volume
15.01 million shs
Average Volume
7.44 million shs
Market Capitalization
$57.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NEOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NEOS Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
MCET MultiCell Technologies, Inc.
NEOS/USD - NeosCoin US Dollar
Cara Therapeutics, Inc. (CARA)
See More Headlines

NEOS Stock Analysis - Frequently Asked Questions

Neos Therapeutics, Inc. (NASDAQ:NEOS) issued its quarterly earnings results on Monday, November, 9th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by $0.05. The business earned $12.54 million during the quarter.

Neos Therapeutics (NEOS) raised $60 million in an initial public offering on Thursday, July 23rd 2015. The company issued 4,000,000 shares at $14.00-$16.00 per share. UBS Investment Bank, BMO Capital Markets and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neos Therapeutics investors own include TherapeuticsMD (TXMD), Onconova Therapeutics (ONTX), Adamis Pharmaceuticals (ADMP), Acasti Pharma (ACST), SCYNEXIS (SCYX), Corbus Pharmaceuticals (CRBP) and AVEO Pharmaceuticals (AVEO).

Company Calendar

Last Earnings
11/09/2020
Today
7/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NEOS
Fax
N/A
Employees
213
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.90 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$64.65 million
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-9.58

Miscellaneous

Free Float
N/A
Market Cap
$57.22 million
Optionable
Optionable
Beta
1.50
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:NEOS) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners